dermatology trials completed
with James M. Swinehart, M.D., as principal investigator since 1984

Areas Studied

  • Psoriasis (topical medications, oral medications, injectable biologics)
  • Hair Loss (oral and topical medications)
  • Actinic Keratosis
  • Acne
  • Fungal Infections (tinea pedis, tinea cruris, tinea corporis, onychomycosis)
  • Skin and Soft Tissue Infections
  • Skin Cancer (basal cell carcinoma, squamous cell carcinoma)
  • Genital Warts (injectables and topicals)
  • Atopic Dermatitis
  • Hand Eczema
  • Seborrheic Dermatitis
  • Xerosis
  • Antipruritics
  • Herpes Zoster
  • Aging-Related Skin Changes and Photodamage
  • Skin Irritancy / Cosmetic Irritancy
  • Common and Plantar Warts
  • Leg Ulcers
  • Alopecia Areata
  • Vitiligo
  • Hyperhidrosis (palmar, axillary)

Current and Upcoming Studies

In the coming months, studies in the following areas are expected to commence as well:

  • moderate/severe plaque psoriasis (January 2021)

Research studies for other skin conditions may be conducted as well. For additional information on the above studies, or other studies at our Center, please call us at (303)744-7000 or write to us at:

Colorado Medical Research Center
950 East Harvard Avenue, Suite 630
Denver, CO 80210

Information For Pharmaceutical Companies

The Colorado Medical Research Center is an independent private clinical research site specializing primarily in dermatology. Its medical director, James M. Swinehart, M.D., is a board-certified dermatologist who has been conducting clinical research for over 20 years, having completed over 140 dermatology trials as principal investigator.

We offer the following services:

  • Phase I; PK Studies
  • Phase IIa; IIb Studies
  • Phase IIIa, IIIb Studies
  • Phase IV Studies
  • Skin photography
  • Electronic CRF submission
  • Protocol review
  • Protocol design
  • Investigator meetings
  • Skin biopsy
  • Fluid collection
  • Access to x-ray, audiograms, EKGs